Therneau, Terry M.

Modeling Survival Data: Extending the Cox Model

Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health

Statistical Methods and InferenceProbability and Statistical Research

Cited by 8,674

Proportional hazards tests and diagnostics based on weighted residuals

GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika

Statistical Methods and InferenceProbability and Statistical Research

Cited by 5,885

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Kyle, R. A., Gertz, M. A., Witzig, T. E., Lust, J. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Rajkumar, S. V., Offord, J. R., Larson, D. R., et al. (2003) · Mayo Clinic Proceedings

Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment

Cited by 2,447

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2002) · New England Journal of Medicine

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 1,475

Prevalence of monoclonal gammopathy of undetermined significance

Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., Offord, J. R., Dispenzieri, A., Katzmann, J. A., & Melton, L. J. (2006) · New England Journal of Medicine

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 1,423

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Gunter, J. L., Senjem, M. L., Jones, D. T., Kantarci, K., et al. (2017) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 931

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Kyle, R. A., Remstein, E. D., Therneau, T. M., Dispenzieri, A., Kurtin, P. J., Hodnefield, J. M., Larson, D. R., Plevak, M. F., Jelinek, D. F., Fonseca, R., et al. (2007) · New England Journal of Medicine

Multiple Myeloma Research and TreatmentsAmyloidosis: Diagnosis, Treatment, Outcomes

Cited by 921

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 772

Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

Kyle, R. A., Larson, D. R., Therneau, T. M., Dispenzieri, A., Kumar, S., Cerhan, J. R., & Rajkumar, S. V. (2018) · New England Journal of Medicine

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 647

Longitudinal tau PET in ageing and Alzheimer’s disease

Jack, C. R., Wiste, H. J., Schwarz, C. G., Lowe, V. J., Senjem, M. L., Vemuri, P., Weigand, S. D., Therneau, T. M., Knopman, D. S., Gunter, J. L., et al. (2018) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 452

Clinical Course of Patients With Relapsed Multiple Myeloma

Kumar, S. K., Therneau, T. M., Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Rajkumar, S. V., Fonseca, R., Witzig, T. E., Lust, J. A., Larson, D. R., et al. (2004) · Mayo Clinic Proceedings

Multiple Myeloma Research and TreatmentsMultiple Sclerosis Research Studies

Cited by 365

Epidemiology and natural history of primary biliary cirrhosis in a U.S. community

Kim, W. R., Lindor, K. D., Locke, G. R., Therneau, T. M., Homburger, H. A., Batts, K. P., Yawn, B. P., Petz, J. L., Melton, L. J., & Dickson, E. R. (2000) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 349

Calculating Sample Size Estimates for RNA Sequencing Data

Hart, S. N., Therneau, T. M., Zhang, Y., Poland, G. A., & Kocher, J.-P. (2013) · Journal of Computational Biology

Gene expression and cancer classificationGenomics and Phylogenetic Studies

Cited by 341

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Knopman, D. S., Lowe, V., Vemuri, P., Mielke, M. M., Roberts, R. O., Machulda, M. M., et al. (2017) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 333

Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia

Jack, C. R., Wiste, H. J., Therneau, T. M., Weigand, S. D., Knopman, D. S., Mielke, M. M., Lowe, V. J., Vemuri, P., Machulda, M. M., Schwarz, C. G., et al. (2019) · JAMA

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 324

Underestimation of liver‐related mortality in the United States

Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., & Kim, W. R. (2013) · Gastroenterology

Liver Disease and TransplantationAlcohol Consumption and Health Effects

Cited by 311

Prevalence of biologically vs clinically defined alzheimer spectrum entities using the National Institute on Aging–Alzheimer's Association Research Framework

Jack, C. R., Therneau, T. M., Weigand, S. D., Wiste, H. J., Knopman, D. S., Vemuri, P., Lowe, V. J., Mielke, M. M., Roberts, R. O., Machulda, M. M., et al. (2019) · JAMA Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 300

Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity

St Sauver, J. L., Boyd, C. M., Grossardt, B. R., Bobo, W. V., Finney Rutten, L. J., Roger, V. L., Ebbert, J. O., Therneau, T. M., Yawn, B. P., & Rocca, W. A. (2015) · BMJ Open

Chronic Disease Management StrategiesPharmaceutical Practices and Patient Outcomes

Cited by 257

Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

Angulo, P., Batts, K. P., Therneau, T. M., Jorgensen, R. A., Dickson, R. E., & Lindor, K. D. (1999) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 234

Identification of Anonymous MRI Research Participants with Face-Recognition Software

Schwarz, C. G., Kremers, W. K., Therneau, T. M., Sharp, R. R., Gunter, J. L., Vemuri, P., Arani, A., Spychalla, A. J., Kantarci, K., Knopman, D. S., et al. (2019) · New England Journal of Medicine

Face recognition and analysisFace Recognition and Perception

Cited by 215

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

Angulo, P., Lindor, K. D., Therneau, T. M., Jorgensen, R. A., Malinchoc, M., Kamath, P. S., & Dickson, E. R. (1999) · Liver International

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 203

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes

Jack, C. R., Wiste, H. J., Botha, H., Weigand, S. D., Therneau, T. M., Knopman, D. S., Graff-Radford, J., Jones, D. T., Ferman, T. J., Boeve, B. F., et al. (2019) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 200

Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis

Lindor, K. D., Jorgensen, R. A., Therneau, T. M., Malinchoc, M., & Dickson, E. R. (1997) · Mayo Clinic Proceedings

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 166

Lumbar Lordosis and Pelvic Inclination in Adults With Chronic Low Back Pain

Youdas, J. W., Garrett, T. R., Egan, K. S., & Therneau, T. M. (2000) · Physical Therapy

Musculoskeletal pain and rehabilitationScoliosis diagnosis and treatment

Cited by 146